Brookline Capital Management Estimates ADIL Q1 Earnings
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Research analysts at Brookline Capital Management issued their Q1 2025 earnings estimates for shares of Adial Pharmaceuticals in a research note issued on Tuesday, March 4th. Brookline Capital Management analyst K. Dolliver forecasts that the company will post earnings per share of ($0.62) for the quarter. The […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Research analysts at Brookline Capital Management issued their Q1 2025 earnings estimates for shares of Adial Pharmaceuticals in a research note issued on Tuesday, March 4th. Brookline Capital Management analyst K. Dolliver forecasts that the company will post earnings per share of ($0.62) for the quarter. The […]
